Viavi (VIAV) insider files Form 144 to sell 13,115 common shares via Morgan Stanley

Rhea-AI Filing Summary

Form 144 filed for Viavi Solutions Inc. (VIAV) shows a proposed sale of 13,115 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $146,560.13. The filing lists the number of outstanding shares as 223,245,915 and identifies the approximate date of sale as 08/29/2025 on NASDAQ. The securities were acquired on 08/28/2025 as restricted stock from the issuer, with payment dated 08/28/2025. The filer reports no securities sold in the past three months. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information and notes reliance possibilities for a Rule 10b5-1 trading plan if applicable. The issuer name and some filer contact details are not provided in the visible content.

Positive

• Execution via a registered broker: The proposed sale is to be handled by Morgan Stanley Smith Barney LLC
• No recent sales reported: The filer reports "Nothing to Report" for securities sold in the past three months

Negative

• Issuer name absent in provided excerpt: The filing content does not display the issuer name in the visible sections
• Very short interval between acquisition and proposed sale: Securities were acquired on 08/28/2025 and the approximate sale date is 08/29/2025

Insights

Securities Analyst

TL;DR: Small insider sale notice for 13,115 shares via a major broker, acquired as restricted stock one day before the proposed sale.

The filing documents a proposed Rule 144 sale of 13,115 common shares valued at $146,560.13, to be executed through Morgan Stanley Smith Barney LLC on NASDAQ. The securities were recorded as acquired from the issuer on 08/28/2025 as restricted stock with payment on the same date and an intended sale on 08/29/2025. The filer reports no sales in the prior three months. For investors, this is a routine insider notice describing a planned sale under Rule 144; the filing itself contains no performance metrics or forward-looking company data.

Corporate Governance Expert

TL;DR: The notice reflects a compliance filing for resale of recently acquired restricted shares, with standard seller certification.

The document includes the seller's representation that they lack undisclosed material adverse information and references Rule 10b5-1 plan adoption language. The transaction is routed through an institutional broker, and the filer indicates no other disposals in the past three months. One governance note: the visible content does not show the issuer name or complete filer contact details, which limits transparency in this excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	13115	146560.13	223245915	08/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/28/2025	Restricted Stock	ISSUER			13115	08/28/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being sold in the VIAV Form 144?

The filing proposes the sale of 13,115 common shares of Viavi Solutions Inc.

When is the proposed sale date listed in the filing?

The approximate date of sale is listed as 08/29/2025.

Through which broker will the VIAV shares be sold?

The filing names Morgan Stanley Smith Barney LLC as the broker.

How were the securities acquired according to the filing?

The securities were acquired on 08/28/2025 as restricted stock from the issuer with payment dated 08/28/2025.

Does the filer report recent sales of VIAV stock?

The filing states "Nothing to Report" for securities sold during the past three months.